QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 36 filers reported holding QUALIGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 4,250,000 | $16,873,000 | 0.26% |
| Virtu Financial LLC | 29,887 | $119,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 29,998 | $119,000 | 0.00% |
| JANE STREET GROUP, LLC | 10,783 | $43,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 537 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| Archer Investment Corp | 160 | $635,000 | 0.00% |
| BlackRock Inc. | 578 | $2,000 | 0.00% |